Across TCGA pan-cancer cohorts, RAB9AP2 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RAB9AP2 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RAB9AP2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RAB9AP2 expression acts as an unfavorable survival marker.

UCEC and OV are the cancer types where RAB9AP2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.198	0.873	<.001	108	view →
OV	DFS	Tertile	All	0.101	0.541	<.001	54	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RAB9AP2 tumor-vs-normal RNA expression · all RAB9AP2 data types